Multi-source·Jul 16, 2026·3 sources analyzed
FDA is taking comments on supervised therapeutic use of psychedelic drugs
A new FDA hearing and public docket ask how psychedelic drugs should be used in supervised settings, including patient safety, provider training, and access standards.
Image: apnews.com
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on FDA oversight of psychedelic therapies
See the current decision, choose your position, and send a message through the issue page.
Take action on FDA oversight of psychedelic therapies